Industry News
Time to rework the funding cycle?
Preparing grant proposals for a single annual deadline is stressful, time-consuming and conflicts with personal responsibilities, a study confirms. [ + ]
Antisense MS candidate well tolerated in monkeys
Antisense Therapeutics' (ASX:ANP) in-licensed MS drug candidate ATL1102 was found to be well tolerated at two dose levels during a long-term animal trial. [ + ]
Prana shares sink after Alzheimer's trial disappoints
Shares in Prana Biotechnology (ASX:PBT) fell 73% after the company revealed that a phase II trial of PBT2 in Alzheimer's disease did not meet its primary and some secondary endpoints. [ + ]
E. coli strain nears complete resistance
Genome sequencing of a multidrug-resistant Escherichia coli strain has revealed this bacterium is close to becoming resistant to almost all antibiotics. [ + ]
E. coli strain close to complete resistance
An international study, led by The University of Queensland (UQ), has been tracking a multidrug-resistant E. coli strain that is only one gene away from being resistant to almost all antibiotics. [ + ]
EKF acquires STI
EKF Diagnostics, a global in vitro diagnostics business, has acquired Separation Technology Inc (STI), a Florida-based manufacturer of in vitro diagnostics devices for haematology testing. [ + ]
Fast-paced evolution of proteins
Researchers have uncovered a new family of seed proteins as well as provided an explanation for 'de novo protein evolution'. [ + ]
FANTOM adds an atlas of human gene expression to the DNA library
The international research consortium FANTOM (Functional Annotation of the Mammalian Genome) has released the first comprehensive map of gene activity across the human body and provided the first holistic view of the complex networks that regulate gene expression across the cell types that make up a human being. [ + ]
Simon McKeon to give National Press Club Address
AusBiotech has welcomed news that Simon McKeon AO will speak at the National Press Club in Canberra about the Strategic Review of Health and Medical Research in Australia. [ + ]
Analytica close to US, EU filings for PeriCoach
Analytica (ASX:ALT) will soon be ready to file EU CE Mark and US 510(k) submissions for PeriCoach, a device for treating female urinary incontinence that is already approved in Australia. [ + ]
pSivida partner files fourth US NDA for Iluvien
pSivida (ASX:PVA) licensee Alimera Sciences has made its third resubmission of its US New Drug Application for diabetic macular edema treatment Iluvien. [ + ]
GI Dynamics hits Netherlands reimbursement milestone
A Dutch hospital has won approval to be reimbursed for some procedures involving GI Dynamics' (ASX:GID) EndoBarrier so that healthcare authorities can evaluate allowing nationwide reimbursement. [ + ]
Academy Fellowships
Twenty-one new fellows have been elected to the Australian Academy of Science. [ + ]
A vaccine for middle ear infections
A team of international researchers has moved a step closer to developing a vaccine to protect against middle ear infection, which could also be used for those with poor lung function. [ + ]
Extreme weather directs insect and reptile distribution
The distribution of cold-blooded creatures such as insects, spiders and skinks is predicted to shift rapidly due to extreme weather events associated with climate change. [ + ]
